Skip to main content

Search

Reset all filters
83 Result(s)
Sort by

Skin Diseases

Skin Diseases

Skin Diseases | We discover and develop breakthrough therapies that can be used to prevent, treat and repair many inflammatory and fibrotic diseases.
Oncology Translational Science

Oncology Translational Science

Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts
Our Expectations

Our Expectations

We are committed to exemplary ethical and professional conduct both within the company and from our suppliers.
Retinal Diseases

Retinal Diseases

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye.
Computational Biology & Digital Sciences

Computational Biology & Digital Sciences

At Boehringer Ingelheim, we are investing into the power of computational biology and data sciences to accelerate the journey from scientific discoveries to breakthrough therapies.
Immune cell directed therapies

Immune cell directed therapies

Boehringer Ingelheim is committed to transforming cancer care, investigating therapies that target cancer cells and boost the immune system for the benefit of patients.
Our Commitment

Our Commitment

Humanity faces great challenges. We believe that we can always do more - for ourselves and for future generations.